PCDH17 is frequently downregulated and meantime hypermethylated in various human carcinomas [48,49,50,51]; it is considered a TSG [48,52,53,54,55], and its biological function in tumour pathogenesis was discovered at first in breast tumour cell lines [54]. Here, PCDH17 is linked to neoplasm.